APYX Dividend: Apyx Medical Corp Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

APYX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	47	48	52	44	48	27
Revenue Growth (YoY)	-2%	-8%	18%	-8%	78%	-4%
Cost of Revenue	17	18	18	15	14	10
Gross Profit	30	29	33	29	33	17
Selling, General & Admin	35	43	48	48	43	33
Research & Development	3	5	4	4	4	3
Operating Expenses	39	48	53	52	48	37
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-14	-23	-21	-22	-14	-19
Income Tax Expense	0	0	-2	0	0	-3
Net Income	-14	-23	-18	-23	-15	-11
Net Income Growth	-50%	28%	-22%	53%	36%	-42%
Shares Outstanding (Diluted)	40.74	35.54	34.62	34.52	34.33	34.21
Shares Change (YoY)	18%	3%	0%	1%	0%	0%
EPS (Diluted)	-0.36	-0.66	-0.54	-0.67	-0.44	-0.34
EPS Growth	-56%	22%	-19%	52%	28.99%	-41%
Free Cash Flow	-9	-18	-5	-21	-11	-16
Free Cash Flow Per Share	-0.22	-0.5	-0.14	-0.6	-0.32	-0.46
Gross Margin	63.82%	60.41%	63.46%	65.9%	68.75%	62.96%
Operating Margin	-19.14%	-37.5%	-36.53%	-52.27%	-29.16%	-74.07%
Profit Margin	-29.78%	-47.91%	-34.61%	-52.27%	-31.25%	-40.74%
Free Cash Flow Margin	-19.14%	-37.5%	-9.61%	-47.72%	-22.91%	-59.25%
EBITDA	-9	-18	-19	-23	-14	-20
EBITDA Margin	-19.14%	-37.5%	-36.53%	-52.27%	-29.16%	-74.07%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-9	-18	-19	-23	-14	-20
EBIT Margin	-19.14%	-37.5%	-36.53%	-52.27%	-29.16%	-74.07%
Effective Tax Rate	0%	0%	9.52%	0%	0%	15.78%